A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03662542 · COMPLETED
Trial details
- NCT number
- NCT03662542
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2020-12-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.